echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Global special drug risk landing Lecheng first area of the new special drug "expensive medicine" is expected to ease.

    Global special drug risk landing Lecheng first area of the new special drug "expensive medicine" is expected to ease.

    • Last Update: 2020-09-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical network August 17th, the first global special drug insurance - Hainan Free Trade Port Boao Le City global special drug insurance released, only two days consumers have purchased more than 100,000 copies.
    the past, the seriously ill patients face foreign new special drugs to wear.
    of the problems they face is the difficulty of buying medicine.
    Since the establishment of the International Medical Tourism Zone in Boao Le City, Hainan Province, this problem has been alleviated, and many new drugs that have not yet been approved in China can also be found in the advance zone;
    In 2013, the State Council approved the establishment of the Lecheng Advance Zone, "licensed medical treatment, franchising, concession research, concession international exchanges" of the "4 concessions" preferential policy, so that the Lecheng Advance Zone can import, use has not yet been approved in The country's new drugs, equipment and equipment, therefore, Lecheng Advance Zone is also known as the "Medical Special Zone."
    as of June this year, the first case of imported licensed drug varieties in Lecheng Pioneer District exceeded 100 cases, and 100 new anti-tumor drugs and rare disease drugs were available.
    51 new anti-tumor drugs corresponding to 70 types of tumor diseases, most of which have not yet been marketed in China, representing the international cutting-edge drug research results.
    In September 2019, the Implementation Plan on Supporting the Construction of the Boao Lecheng International Medical Tourism Advance Zone clearly states that the import approval of drugs and medical devices in the advance area shall be accelerated, and on the basis of the patient filing commitment, it is conditional on allowing patients in the medical institutions in the advance area to leave the advance zone for the use of imported drugs with reasonable amounts of their own use.
    , Hainan Governor Shen Xiaoming told a press conference at the State Administration of China that about 600,000 people go abroad every year to see a doctor, in order to seek the best drugs and the best medical equipment abroad.
    the current state of domestic regulation, it will take at least five years for the best drugs and devices to enter the domestic market.
    policy will greatly shorten the time it takes for innovative drugs from around the world to enter the Chinese market.
    , a foreign anti-cancer drug, from the first area of hospitals to apply for patient medication, only a few days.
    time is shortened, the cost of medication is still high, how to make people can use, can also afford to use? Reporters learned that, at present, the Lecheng Administration is working with Yuanhe Huibao to carry out the "Boao Lecheng International Medical Tourism Zone Insurance Integrated Service Platform" construction, the two sides will work with many insurance companies at home and abroad to create "overseas referral, special drug insurance, single-disease insurance" and other high-quality health insurance products, with commercial insurance to reduce the pressure of medical insurance, improve the "domestically listed drugs" delivery and pharmaceutical services, while reducing the "not listed drugs in China" on the economic burden on patients.
    Lecheng Management Bureau Director Gu Gang said that in view of the high price of new special drugs abroad, Lecheng give full play to the special policies granted by the state, innovative "health insurance and commercial insurance" mechanism, improve the multi-level security system, the application of new special drugs in medical services to protect the expenditure, so that high-quality medical resources benefit the people of the country.
    , CEO of Yuanyuan Huibao Technology Co., Ltd., said that the first landing of Lecheng global special drug insurance is a good start.
    With the help of this universal product, Hainan residents can enjoy new anti-cancer drugs not listed in China, make up for the cost of other drugs other than medical insurance reimbursement, and really solve the economic pressure brought about by the drug for major diseases, and solve the real problem of local patients "difficult to buy medicine, expensive to buy medicine, difficult to use medicine" at an early date.
    Is different from the previous Chinese market special drug insurance products, Lecheng global special drug insurance coverage in addition to the domestic market has been listed 21 special drugs, including 49 kinds of overseas special drugs not listed in China, many of which are developed with the latest technology.
    These 21 domestic listed medical insurance products and 49 overseas special drugs basically cover the cancer treatment-related out-of-the-money products, and this product has no age and occupation restrictions, the annual premium per capita is only 29 yuan.
    the issue of commercial insurance payments has always been a "pain point" for consumers.
    Global Special Drug Insurance opened up commercial insurance and health insurance, to achieve direct settlement, but also to make consumers pay more smoothly.
    It is learned that Lecheng Global Special Drug Insurance opened 32 medical institutions in Hainan Province and other in-hospital drug fee direct closing services, to achieve the risk of user claims after the approval, to the designated hospital by virtue of commercial insurance vouchers, in the hospital to achieve the direct conclusion of pharmaceutical costs within the scope of commercial insurance.
    If the need for overseas listed special drug treatment, the risk user needs to be treated in the first district fixed-point hospital, claims audit passed, by virtue of commercial insurance vouchers, no need for patients to advance overseas drug charges, you can complete the overseas drug claims straight.
    even if there is no required medicine in the hospital, consumers can rely on insurance certificates and related prescriptions and other materials, to the designated pharmacy to complete the purchase of drugs and direct compensation services.
    Peng said that the opening of social security and commercial insurance reimbursement channels in hospitals in Hainan Province has solved the problem of "money" for ordinary people, allowing patients to use drugs that are more suitable for their condition, and no longer worry about the economic pressure on individuals and families caused by out-of-own medicines because they are "not covered by social security".
    at the same time, the opening of social security and commercial insurance reimbursement channels in hospitals, so that Lecheng global special drug insurance and social security in the reimbursement service experience, greatly reduce the cost of patient reimbursement time, and truly achieve seamless link.
    , the model is expected to be rolled out across the country.
    Peng Wei introduced, to Lecheng global special drug insurance as a starting point, the future will be Lecheng global drug insurance model to open up more cities, so that more people in cities can enjoy the treatment of domestic un-listed drugs in Hainan.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.